To prove the presence of this receptor on DRG neurons, we employed the spatial transcriptome technology (Nanostring GeoMx DSP) platform to quantify and to compare the expression of the whole mouse transcriptome in the DRG of our TPAC model in simultaneous comparison with oncogenic Kras-based mouse models of pancreatic cancer and with WT mice. The gene discussed is KRAS; the disease is pancreatic neoplasm.